REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

GP Rb Buryat-Farmatsiya (Russia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Merchant Wholesalers, Nondurable Goods | Health and Personal Care Stores
Full name: GP Respubliki Buryatiya Buryat-Farmatsiya Profile Updated: March 07, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

GP Respubliki Buryatiya Buryat-Farmatsiya is a state enterprise. It is the main supplier of medicines in the Republic of Buryatia, offering a wide range of pharmaceutical services, including specific drugs, vaccines, and medical devices. The company has a warehouse complex and its own car park for delivering medications to all regions of Buryatia, and they are the sole supplier of vaccines for the prevention of coronavirus infection in the region.

Headquarters
Ulitsa Dalnevostochnaya, 7
Ulan-Ude; Buryatia Republic; Postal Code: 670047

Contact Details: Purchase the GP Rb Buryat-Farmatsiya report to view the information.

Website: http://burfarm.ru

Basic Information
Outstanding Shares:
Purchase the GP Rb Buryat-Farmatsiya report to view the information.
Registered Capital:
Purchase the GP Rb Buryat-Farmatsiya report to view the information.
Incorporation Date:
July 03, 2000
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Aptechnyi Punkt Apteki N1 Respubliki Buryatiya Buryat-Farmatsiya GP
100%
Apteka N 4 Respubliki Buryatiya Buryat-Farmatsiya GP
100%
Company Performance
Financial values in the chart are available after GP Rb Buryat-Farmatsiya report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-19.65%▼
Total operating revenue
-19.65%▼
Operating profit (EBIT)
-51.4%▼
Net Profit (Loss) for the Period
-89.09%▼
Total assets
-38.63%▼
Total equity
-12.2%▼
Operating Profit Margin (ROS)
-1.16%▼
Net Profit Margin
-1.91%▼
Return on Equity (ROE)
-53.62%▼
Quick Ratio
-0.17%▼
Cash Ratio
0.06%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo